CDR2 Polyclonal Antibody

Background:
CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer.

Research Area: Cancer, Immunology

Synonyms:
AA617262, CDR 2, CDR 62, CDR2, CDR2, CDR62, Cerebellar degeneration related protein 2 62kDa, Cerebellar degeneration related protein 2, Cerebellar degeneration related protein, Cerebellar degeneration-related protein 2, Major Yo paraneoplastic antigen, MGC116181, MGC144810, MGC144811, Paraneoplastic cerebellar degeneration associated antigen, Paraneoplastic cerebellar degeneration-associated antigen, PCD 17, PCD17, RGD1310578, Yo, Yo paraneoplastic antigen

Immunogen: Recombinant protein of human CDR2

Swissprot: Q01850
Gene Accession: BC017503

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.4 mg/mL
Dilution: IHC 1:50-1:200

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-109228